The ISFA wishes to acknowledge the following 2013 Corporate Sponsors
Invitation to Hangzhou for the International Society for Apheresis Congress 2013
Treatment of Severe Genetic Dyslipidemia: Where Are We Going?
Updates in Apheresis and Atherosclerotic Research
Current Ways of Treating Dyslipidemias to Prevent Atherosclerosis
Severe Hypertriglyceridemia-Related Acute Pancreatitis
Multi-Modal Imaging Technologies in Cardiovascular Risk Assessment
Management of Inherited Atherogenic Dyslipidemias in Children
Prevention and Treatment of Cardiovascular Disease in Women: The Obstetric-Gynecologist's Point of View
Italian Multicenter Study on Low-Density Lipoprotein Apheresis Working Group 2009 Survey
Why an Apheresis Center Should Offer More Than One Lipoprotein Apheresis Method
Therapeutic Potential of Low-Density Lipoprotein Apheresis in the Management of Peripheral Artery Disease in Patients With Chronic Kidney Disease
Novel Inflammatory Marker in Dialysis Patients: YKL-40
Regional Citrate Anticoagulation for High Volume Continuous Venovenous Hemodialysis in Surgical Patients With High Bleeding Risk
Risk Factors for Recurrence of Immunoglobulin A Nephropathy After Renal Transplantation: Single Center Study
Serum Phosphate and Calcium Should Be Primarily and Consistently Controlled in Prevalent Hemodialysis Patients
2011 JSDT Standard on the Management of Endotoxin Retentive Filter for Dialysis and Related Therapies
Differences in Reduction of Coagulation Factor XIII (F13) Between Immunoadsorption Plasmapheresis and Double Filtration Plasmapheresis
Drugs Affecting the Renin-Angiotensin System and Preservation of Residual Renal Function in Dialysis Patients
Effect of Renin-Angiotensin System Inhibitor on Residual Glomerular Filtration Rate in Hemodialysis Patients
Upcoming Meetings